Joseph Dardick

Joseph Dardick

Auto-generated profile, based on publicly available information

Joseph Dardick

Department of Neurosurgery, Johns Hopkins University School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2018 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
KJKerstin M. Janisch
Kerstin M. Janisch
KMKatrina C. McNeely
Katrina C. McNeely
JDJoseph M. Dardick
Joseph M. Dardick
SLSamuel H. Lim
Samuel H. Lim
DNDwyer Noelle
Dwyer Noelle
KIF20B is in the Kinesin-6 family that includes KIF23/MKLP1 and KIF20A/MKLP2. Previously we showed that mouse Kif20b regulates cerebral cortex growth and neural stem cell midbodies. Now we show KIF20B has a cell-autonomous role in regulating cytokinetic furrowing and abscission. KIF20B may coordinate late midbody maturation before abscission.

25 August 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
CECharles Esenwa
Charles Esenwa
NCNatalie T. Cheng
Natalie T. Cheng
JLJorge Luna
Jorge Luna
JWJoshua Willey
Joshua Willey
ABAmelia K. Boehme
Amelia K. Boehme
SYShadi Yaghi
Shadi Yaghi
Background and Purpose: We sought to determine if biomarkers of inflammation and coagulation can help define coronavirus disease 2019 (COVID-19)–associated ischemic stroke as a novel acute ischemic stroke (AIS) subtype. Methods: We performed a machine learning cluster analysis of common biomarkers in patients admitted with severe acute respiratory syndrome coronavirus 2 to determine if any were associated with AIS. Findings were validated using aggregate data from 3 large healthcare systems. Results: Clustering grouped 2908 unique patient encounters into 4 unique biomarker phenotypes based on levels of c-reactive protein, D-dimer, lactate dehydrogenase, white blood cell count, and partial thromboplastin time. The most severe cluster phenotype had the highest prevalence of AIS (3.6%, P <0.001), in-hospital AIS (53%, P <0.002), severe AIS (31%, P =0.004), and cryptogenic AIS (73%, P <0.001). D-dimer was the only biomarker independently associated with prevalent AIS with quartile 4 having an 8-fold higher risk of AIS compared to quartile 1 ( P =0.005), a finding that was further corroborated in a separate cohort of 157 patients hospitalized with COVID-19 and AIS. Conclusions: COVID-19–associated ischemic stroke may be related to COVID-19 illness severity and associated coagulopathy as defined by increasing D-dimer burden.

30 August 2020 in Interventional Neuroradiology
Verified
Journal Article
Open access
PDF file
DADavid J. Altschul
David J. Altschul
CECharles Esenwa
Charles Esenwa
NHNeil Haranhalli
Neil Haranhalli
SUSantiago Unda
Santiago Unda
RRRafael de La Garza Ramos
Rafael de La Garza Ramos
RZRichard Zampolin
Richard Zampolin
Background: This study evaluates the mortality risk of patients with emergent large vessel occlusion (ELVO) and COVID-19 during the pandemic. Methods: We performed a retrospective cohort study of two cohorts of consecutive patients with ELVO admitted to a quaternary hospital from March 1 to April 17, 2020. We abstracted data from electronic health records on baseline, biomarker profiles, key time points, quality measures and radiographic data. Results: Of 179 patients admitted with ischemic stroke, 36 had ELVO. Patients with COVID-19 and ELVO had a higher risk of mortality during the pandemic versus patients without COVID-19 (OR 16.63, p = 0.004). An age-based sub-analysis showed in-hospital mortality in 60% of COVID-19 positive patients between 61-70 years-old, 66.7% in between 51-60 years-old, 50% in between 41-50 years-old and 33.3% in between 31-40 years old. Patients that presented with pulmonary symptoms at time of stroke presentation had 71.4% mortality rate. 27.3% of COVID-19 patients presenting with ELVO had a good outcome at discharge (mRS 0-2). Patients with a history of cigarette smoking (p = 0.003), elevated d-dimer (p = 0.007), failure to recanalize (p = 0.007), and elevated ferritin levels (p = 0.006) had an increased risk of mortality. Conclusion: Patients with COVID-19 and ELVO had a significantly higher risk for mortality compared to COVID-19 negative patients with ELVO. A small percentage of COVID-19 ELVO patients had good outcomes. Age greater than 60 and pulmonary symptoms at presentation have higher risk for mortality. Other risk factors for mortality were a history of cigarette smoking, elevated, failure to recanalize, elevated d-dimer and ferritin levels.

20 September 2019 in Surgical Neurology International
Verified
Journal Article
Open access
JDJoseph Dardick
Joseph Dardick
SAStephanie Allen
Stephanie Allen
ASAleka Scoco
Aleka Scoco
RZRichard L. Zampolin
Richard L. Zampolin
DADavid J. Altschul
David J. Altschul
Background: Realistic virtual reality (VR) simulators have greatly expanded the tools available for training surgeons and interventionalists. While this technology is effective in improving performance in many fields, it has never been evaluated for neuroendovascular procedures. This study aims to determine whether VR is an effective tool for improving neuroendovascular skill among trainees. Methods: Trainees performed two VR revascularizations of a right-sided middle cerebral artery (MCA) thrombosis and their times to procedural benchmarks (time to enter internal carotid artery [ICA], traverse clot, and complete procedure) were compared. To determine whether the improvement was case specific, trainees with less procedural exposure were timed during VR left-sided ICA (LICA) aneurysm coiling before or after performing MCA thrombectomy simulations. To determine the value of observing simulations, medical students were timed during the right MCA revascularization simulations after watching other VR procedures. Results: Trainees significantly improved their time to every procedural benchmark during their second MCA revascularization (mean decrease = 1.08, 1.57, and 2.24 min; P = 0.0072, 0.0466, and 0.0230). In addition, time required to access the LICA during aneurysm coiling was shortened by 0.77 min for each previous VR right MCA revascularization performed (P = 0.0176; r2 = 0.71). Finally, medical students’ MCA revascularization simulation times improved by 0.87 min for each prior simulation viewed (P < 0.0221; r2 = 0.96). Conclusion: Both performance and viewing of simulated procedures produced significant decreases in time to reach neuroendovascular procedural benchmarks. These data show that VR simulation is a valuable tool for improving trainee skill in neuroendovascular procedures.

10 February 2022 in World Neurosurgery
Verified
Journal Article
Closed access
CFChaim M. Feigen
Chaim M. Feigen
JVJuan Vivanco-Suarez
Juan Vivanco-Suarez
KJKainaat Javed
Kainaat Javed
JDJoseph M. Dardick
Joseph M. Dardick
RHRyan Holland
Ryan Holland
DADavid J. Altschul
David J. Altschul

3 September 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
DADavid J. Altschul
David J. Altschul
NHN. Haranhalli
N. Haranhalli
CECharles Esenwa
Charles Esenwa
SUSantiago Unda
Santiago Unda
RRRafael De la Garza Ramos
Rafael De la Garza Ramos
RZR. Zampolin
R. Zampolin
BACKGROUND AND PURPOSE: Our hypothesis is that the COVID-19 pandemic led to delayed presentations for patients with acute ischemic stroke. This study evaluates the impact of the coronavirus disease 2019 pandemic on presentation, treatment, and outcomes of patients with emergent large-vessel occlusion using data from a large health system in the Bronx, New York. MATERIALS AND METHODS: We performed a retrospective cohort study of 2 cohorts of consecutive patients with emergent large-vessel occlusion admitted to 3 Montefiore Health System hospitals in the Bronx from January 1 to February 17, 2020, (prepandemic) and March 1 to April 17, 2020 (pandemic). We abstracted data from the electronic health records on presenting biomarker profiles, admission and postprocedural NIHSS scores, time of symptom onset, time of hospital presentation, time of start of the thrombectomy procedure, time of revascularization, presenting ASPECTS, TICI recanalization score, mRS, functional outcomes, and mortality. RESULTS: Of 179 patients admitted with ischemic stroke during the study periods, 80 had emergent large-vessel occlusion, of whom 36 were in the pandemic group. Patients in the pandemic group were younger (66 versus 72 years, P < .061) and had lower ASPECTS (7 versus 9, P < .001) and took longer to arrive at the hospital (361 versus 152 minutes, P < .004) with no other major differences. There was a decreased rate of thrombolysis administration (22% versus 43%, P < .049) and a decreased number of patients treated with mechanical thrombectomy (33% versus 61%, P < .013). CONCLUSIONS: The pandemic led to delays in patients arriving at hospitals, leading to decreased patients eligible for treatment, while in-hospital evaluation and treatment times remain unchanged.